Pharnext France Stock Price, News & Analysis

PNEXF OTC

Company Description

Pharnext France (OTC: PNEXF) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector.

PNEXF stock has gained 999900.0% over the past year.

This page provides a comprehensive overview of PNEXF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+999900%

Performance 1 year

$0.0

Market Cap

78.0

Shares outstanding

Pharnext France (PNEXF) stock. Over the past 12 months, the stock has gained 999900.0%.

Latest News

View All

April 27, 2021

0.00%

Pharnext Reports Financial Results for Year-End 2020

earnings

March 31, 2021

0.00%

Pharnext Announces First Patient Enrolled in the PREMIER Trial, its Pivotal Phase III Clinical Development Program of PXT3003 in Charcot-Marie-Tooth Disease Type 1A ('CMT1A')

clinical trial

February 4, 2021

0.00%

Pharnext Announces Financing of €11 Million Through a Capital Raise Subscribed by Existing Shareholders and a Convertible Bonds Issued to European Investors

Pharnext France has 3 recent news articles. Key topics include earnings, clinical trial. View all PNEXF news →

SEC Filings

View All

No SEC filings available for PNEXF.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

PNEXF Company Profile & Sector Positioning

Pharnext France (PNEXF) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the OTC.